OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform
OptymEdge has hired Amy Del Medico as Senior
Director, Project Delivery & Transformation, to lead the scale-up and
global roll-out of ACUVERA — an integrated, AI-powered suite of technology
solutions purpose-built for ophthalmology clinical trials. The platform will be
soft-launched at next month’s American Academy of Ophthalmology (AAO) event in
Orlando.
Del
Medico brings more than 20 years of clinical trial experience across CROs and
biopharma innovators. She spent 17 years at IQVIA, where she served as Director
of the Center of Excellence for Ophthalmology, and most recently was Head of
Clinical Operations at Vial.
Ophthalmology
clinical trials are entering a new era of digital transformation, and OptymEdge
is leading the industry in the adoption and integration of Visual Function Data
Capture Solutions with advanced imaging, AI and analytics. Significantly,
ACUVERA will seamlessly connect sites, sponsors, and CROs. By
standardizing workflows and enabling real-time access to imaging and clinical
data, it ensures more consistent results, allowing faster decision making.
“It’s a really exciting time for the business as we lead the
digital transformation of ophthalmology clinical trials,” said Del
Medico. “My focus will be on driving the global roll-out
and adoption of the ACUVERA suite, which includes digital solutions for
certification, data capture and ophthalmic image reading. Together, these new
tools will enhance data quality and trial efficiency, and my goal is to ensure
our delivery team can apply these new technologies and tools while bringing
measurable impact to our customers and patients.”
ACUVERA has been designed from the ground up as a bespoke
solution. Unlike broad eClinical platforms, it combines deep therapeutic
expertise with automation, RBQM insights, and endpoint-specific intelligence to
deliver best-in-class Visual Function data capture, imaging, and certification.
Del Medico added, “By unifying these critical workflows within a single,
secure platform, sponsors and CROs can reduce operational complexity, improve
endpoint quality, and accelerate study timelines. With many trials now looking
to Asia and its large recruitment base, the key challenge is integrating
processes across regions - particularly given the diversity of sites and
evolving regulatory landscapes. ACUVERA will play a crucial role in harmonizing
data, ensuring compliance, and enabling seamless collaboration across regions.”
-ENDS-
Notes to editors:
For media inquiries, please
contact:
Dana Roche
Director, Marketing & Communications, Emmes